Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting

Collaborators, Affiliations

PARABLE Trial Management Group:
C Taylor¹⁰, C Kirwan¹¹, D Lines¹², E Provenzano¹³, I Gleeson¹³, I Bhattacharya¹³, J Wolstenholme¹⁰, M Aznar¹⁴, M Merchant¹², P Howe¹³, R Butt¹⁵, S Gulliford¹⁶, S Settatree¹⁷, S McMahon¹⁸, T Richards¹⁶, Y Tsang¹⁵, F Cafferty¹⁹, C Toms¹⁹, E Redman¹⁹, K Biscombe¹⁹

¹ The Institute of Cancer Research, London, UK; The Royal Marsden Hospital, Sutton, UK. Electronic address: anna.kirby@rmh.nhs.uk.
² The Institute of Cancer Research, London, UK; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
³ Independent Cancer Patients' Voice, UK.
⁴ NCRI CTRad Consumer Advocate, UK.
⁵ Department of Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK.
⁶ Radiotherapy Department, University College London Hospital NHS Foundation Trust, London, UK.
⁷ National Radiotherapy Trials Quality Assurance Group (RTTQA), Mount Vernon Hospital, Northwood, UK.
⁸ Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
⁹ Department of Oncology, University of Cambridge, Cambridge, UK.
¹⁰ University of Oxford, UK.
¹¹ University Hospital of South Manchester, UK.
¹² The Christie, Manchester, UK.
¹³ Addenbrookes Hospital, UK.
¹⁴ University of Manchester, UK.
¹⁵ National Radiotherapy Trials Quality Assurance Group, Mount Vernon Hospital, UK.
¹⁶ University College London Hospital, UK.
¹⁷ The Institute of Cancer Research and the Royal Marsden Hospital, UK.
¹⁸ Queen's University Hospital, Belfast, UK.
¹⁹ Clinical Trials and Statistics Unit, The Institute of Cancer Research, UK.

Editorial

A M Kirby et al. Clin Oncol (R Coll Radiol). 2023 Jun.

. 2023 Jun;35(6):347-350.

doi: 10.1016/j.clon.2023.02.015. Epub 2023 Mar 2.

PARABLE Trial Management Group:
C Taylor¹⁰, C Kirwan¹¹, D Lines¹², E Provenzano¹³, I Gleeson¹³, I Bhattacharya¹³, J Wolstenholme¹⁰, M Aznar¹⁴, M Merchant¹², P Howe¹³, R Butt¹⁵, S Gulliford¹⁶, S Settatree¹⁷, S McMahon¹⁸, T Richards¹⁶, Y Tsang¹⁵, F Cafferty¹⁹, C Toms¹⁹, E Redman¹⁹, K Biscombe¹⁹

¹ The Institute of Cancer Research, London, UK; The Royal Marsden Hospital, Sutton, UK. Electronic address: anna.kirby@rmh.nhs.uk.
² The Institute of Cancer Research, London, UK; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
³ Independent Cancer Patients' Voice, UK.
⁴ NCRI CTRad Consumer Advocate, UK.
⁵ Department of Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK.
⁶ Radiotherapy Department, University College London Hospital NHS Foundation Trust, London, UK.
⁷ National Radiotherapy Trials Quality Assurance Group (RTTQA), Mount Vernon Hospital, Northwood, UK.
⁸ Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
⁹ Department of Oncology, University of Cambridge, Cambridge, UK.
¹⁰ University of Oxford, UK.
¹¹ University Hospital of South Manchester, UK.
¹² The Christie, Manchester, UK.
¹³ Addenbrookes Hospital, UK.
¹⁴ University of Manchester, UK.
¹⁵ National Radiotherapy Trials Quality Assurance Group, Mount Vernon Hospital, UK.
¹⁶ University College London Hospital, UK.
¹⁷ The Institute of Cancer Research and the Royal Marsden Hospital, UK.
¹⁸ Queen's University Hospital, Belfast, UK.
¹⁹ Clinical Trials and Statistics Unit, The Institute of Cancer Research, UK.

No abstract available

Publication types